Tyrey L
Duke University Medical Center, Durham, North Carolina.
Obstet Gynecol Clin North Am. 1988 Sep;15(3):457-75.
The successful treatment of gestational trophoblastic disease has been partially achieved because of the ability to quantitate serum or urinary concentrations of human chorionic gonadotropin (hCG). Thus, the hCG assay has become essential to the clinical management of trophoblastic disease. This article reviews the various assay methods and discusses their limitations.
由于能够定量检测血清或尿液中人绒毛膜促性腺激素（hCG）的浓度，妊娠滋养细胞疾病的成功治疗已部分实现。因此，hCG检测已成为滋养细胞疾病临床管理的关键。本文回顾了各种检测方法并讨论了它们的局限性。
